GlassScriptPhysician profile
Tarah Czyzewski
NPI 1114798774
$1,897.31
in general payments reported to CMS, 2019-2025
15 companies · $995 in 2025
The $995 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $902 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $411.19 | 2024-2025 | Relistor |
| Abbvie INC. | $328.22 | 2024-2025 | |
| Boston Scientific Corporation | $314.84 | 2024-2025 | Intracept |
| Radius Health, INC. | $262.48 | 2024-2025 | Tymlos |
| Globus Medical, INC. | $223.47 | 2025 | Senza |
| Nevro Corp. | $143.28 | 2024 | Senza |
| Saluda Medical Americas, INC. | $39.27 | 2024-2025 | Evoke |
| Azurity Pharmaceuticals, INC. | $35.13 | 2024 | Horizant |
| Nalu Medical, INC. | $24.42 | 2025 | Nalu Neurostimulation System |
| Bioventus LLC | $23.62 | 2025 | Xcell |
| Collegium Pharmaceutical, INC. | $23.54 | 2025 | Xtampza |
| Curonix LLC | $18.23 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $17.55 | 2025 | Evenity |
| Pfizer INC. | $17.41 | 2024 | |
| Valinor Pharma, LLC | $14.66 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarah Czyzewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.